Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharm-country symbols : Stim save search
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is VitalLack of early symptom improvement is not predictive of final responder status
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: 1.18%
H: 4.28%
C: 1.17%
publication treatment
NeuroStar Achieves Milestone Regulatory Clearance in South Korea First International Approval for Expanded Indication and Certification for MT Cap and D-Tect™ Technologies
Published: 2023-07-17 (Crawled : 14:00) - biospace.com/
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: 2.45%
H: 1.44%
C: -2.39%
certification approval neurostar international clearance milestone
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 5, 2023
Published: 2023-05-05 (Crawled : 13:00) - biospace.com/
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: 0.44%
H: 2.65%
C: 0.44%
nasdaq grant
Neuronetics Reports Record Fourth Quarter and Record Full Year 2022 Financial and Operating Results
Published: 2023-03-07 (Crawled : 13:00) - biospace.com/
GBNH | $0.121 -4.88% 6M
|
Manufacturing
|
| O: -5.61%
H: 5.94%
C: -0.5%
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: -8.64%
H: 0.0%
C: -11.55%
year financial results
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2022 Financial Results
Published: 2023-01-09 (Crawled : 18:00) - biospace.com/
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: 0.91%
H: 3.0%
C: -1.8%
year financial results
Neuronetics Announces 510(k) Clearance of D-Tect™ MT Accessory for NeuroStar® Advanced Therapy for Mental HealthLatest NeuroStar innovation to simplify the motor threshold determination for clinicians
Published: 2022-08-29 (Crawled : 13:00) - biospace.com/
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: -2.17%
H: 3.13%
C: -4.43%
neurostar clearance therapy innovation
Neuronetics Reports Second Quarter 2022 Financial and Operating Results
Published: 2022-08-02 (Crawled : 13:20) - biospace.com/
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: 1.41%
H: 2.78%
C: -1.39%
results
Neuronetics Recognized as Top Non-Invasive Devices Provider in 2022Technology is awarded for its innovation to treat depression with NeuroStar Advanced Therapy for Mental Health
Published: 2022-07-13 (Crawled : 16:00) - biospace.com/
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: -1.43%
H: 14.49%
C: 7.25%
health neurostar therapy innovation depression
NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of Obsessive-Compulsive DisorderClearance allows for more access to non-drug, noninvasive treatment for patients suffering from MDD or OCD
Published: 2022-05-10 (Crawled : 13:20) - biospace.com/
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: 3.52%
H: 0.0%
C: 0.0%
neurostar treatment fda clearance health therapy
Neuronetics to Report First Quarter 2022 Financial and Operating Results and Host Conference Call
Published: 2022-04-28 (Crawled : 19:00) - biospace.com/
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: 4.89%
H: 0.0%
C: -5.38%
conference report results
Neuronetics Announces 510(k) Clearance of MT Cap Technology for NeuroStar® Advanced Therapy for Mental HealthTechnology will save practitioners and patients time during motor threshold determination
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: 2.4%
H: 2.11%
C: -1.17%
neurostar health clearance save technology star therapy
Neuronetics to Report Third Quarter 2021 Financial and Operating Results and Host Conference Call
Published: 2021-10-26 (Crawled : 14:00) - biospace.com/
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: 2.86%
H: 0.0%
C: 0.0%
results conference
New Data Highlights NeuroStar® Advanced Therapy for Mental Health Safety Over H-Coil TMSPeer-Reviewed Paper is Largest Real-World Data Set of TMS Seizure Risk Across Device Manufacturers
Published: 2021-09-21 (Crawled : 14:00) - biospace.com/
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: 2.83%
H: 0.92%
C: -5.04%
risk therapy device
Neuronetics To Present Clinical Data at The American Psychiatric Association 2021 Annual MeetingNeuronetics will share real-world clinical data on its NeuroStar® Advanced Therapy treatment during the virtual event
Published: 2021-04-29 (Crawled : 14:00) - biospace.com/
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: 2.34%
H: 0.0%
C: -7.95%
treatment therapy
Neuronetics Announces Retirement of Gregory Harper, Vice President, R&D and Clinical
Published: 2021-03-11 (Crawled : 22:03) - biospace.com/
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: 2.57%
H: 1.9%
C: 1.76%
Neuronetics Announces Strategic Leadership Promotions to Support Future GrowthElevated roles announced for executive team members Steve Furlong, Greg Harper and Kara Thornton
Published: 2021-02-11 (Crawled : 14:00) - biospace.com/
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: 0.0%
H: 3.87%
C: 2.13%
ev growth
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.